Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
Chromogranin-A (CgA), as measured in the circulation by RIA, has emerged as a useful probe of exocytotic sympathoadrenal activity in man as well as of the presence and extent of neuroendocrine neoplasia. Here we studied, using a sensitive RIA, the distribution of CgA immunoreactivity in normal human neuroendocrine tissues. Furthermore, to investigate whether these normal tissue sources measurably contribute to plasma CgA, we measured plasma CgA, catecholamine, and other polypeptide hormone responses to selective stimuli of secretion at several sites within the neuroendocrine system. Immunoreactive CgA was ubiquitous in human neuroendocrine tissues, in rank order of concentration (micrograms per g wet wt): adrenal medulla greater than pituitary greater than pancreas greater than stomach greater than small intestine (jejunoileum) greater than brain (frontal cortex) greater than parathyroid greater than thyroid. Quantitatively, neuroendocrine tissues other than the adrenal medulla possessed only 0.04-25% of the immunoreactivity found in the adrenal medulla. Insulin-induced hypoglycemia, a potent stimulus of adrenomedullary secretion, resulted in 1.7- and 14-fold rises in plasma CgA and epinephrine, respectively. However, insulin-induced hypoglycemia failed to perturb plasma CgA in three bilaterally adrenalectomized patients, suggesting that the adrenal medulla is the source of plasma CgA elevation during hypoglycemia in normal subjects. Cell type-selective secretagogue stimulation of normal endocrine secretory cells other than the adrenal medulla (pituitary, pancreas, gut, thyroid, and parathyroid) induced measurable increments in the concentrations of the resident peptide hormones, but left plasma CgA unperturbed. Nonselective stimulation of a wide variety of endocrine secretory cells with pentagastrin elevated plasma CgA 1.4-fold. However, restriction of pentagastrin's targets by coinfusion of calcium abolished the effect on plasma CgA. Hence, within the normal human neuroendocrine system, only selective stimulation of the adrenal medulla is likely to elevate plasma CgA under physiological or pharmacological circumstances. This is consistent with our finding of the adrenal medulla as the quantitatively major normal neuroendocrine tissue source of CgA immunoreactivity.
Takiyyuddin
M A
MA
Department of Medicine, University of California, San Diego.
Cervenka
J H
JH
Pandian
M R
MR
Stuenkel
C A
CA
Neumann
H P
HP
O'Connor
D T
DT
D000313:Adrenal Medulla / Q000187:drug effects / Q000378:metabolism; D000315:Adrenalectomy; D001786:Blood Glucose / Q000032:analysis; D002118:Calcium; D053379:Chromogranin A; D002864:Chromogranins / Q000097:blood / Q000378:metabolism*; D004492:Edetic Acid; D004702:Endocrine Glands / Q000378:metabolism*; D004837:Epinephrine / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D007987:Gonadotropin-Releasing Hormone; D006728:Hormones / Q000097:blood; D006801:Humans; D007328:Insulin; D007700:Kinetics; D008297:Male; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D009638:Norepinephrine / Q000097:blood; D010418:Pentagastrin; D011247:Pregnancy; D012016:Reference Values; D013973:Thyrotropin-Releasing Hormone
D001786:Blood Glucose; C506150:CHGA protein, human; D053379:Chromogranin A; D002864:Chromogranins; D006728:Hormones; D007328:Insulin; D009419:Nerve Tissue Proteins; D007987:Gonadotropin-Releasing Hormone; D013973:Thyrotropin-Releasing Hormone; D004492:Edetic Acid; D010418:Pentagastrin; D002118:Calcium; D009638:Norepinephrine; D004837:Epinephrine